Independent Director · Taysha Gene Therapies, Inc. (TSHA)

Alison Long, M.D., Ph.D director compensation at Taysha Gene: $463K

Fiscal year 2025 director compensation for Alison Long, M.D., Ph.D at Taysha Gene Therapies, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 22, 2026 (DEF 14A). Open the filing on EDGAR.

Track this executive's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

What they were paid

Taysha Gene Therapies Director Compensation Table · all 2 fiscal years held
In US dollars, as Taysha Gene Therapies reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$71,917$157,978$232,607—$462,502
FY2024$54,083$156,027$231,334$0$441,444

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Taysha Gene Therapies, Inc. DEF 14A filed April 22, 2026, accession 0001193125-26-168525, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Taysha Gene Therapies, Inc. filed document, accession 0001193125-26-168525. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2026.

That is Alison Long, M.D., Ph.D’s FY2025 figure, as filed. The FY2026 figure the day it is filed: one email, nothing else.

Saved. One email when Alison Long, M.D., Ph.D’s next annual disclosure lands here, with the figure.

One email when Alison Long, M.D., Ph.D’s next annual disclosure is on this page, with the figure. Nothing else is sent.

Get the Taysha Gene Therapies Board Governance Report

$462,502 Alison Long, M.D., Ph.D, FY2025 total director compensation

$499

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 22, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Taysha Gene Therapies pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Compensation

The rest of the Taysha Gene Therapies board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Phillip B. Donenberg, CPAIndependent Director$445,585
Sean P. NolanChair of the Board—
Sean StalfortIndependent Director$441,085
Sukumar Nagendran, M.DDirector—

The full Taysha Gene Therapies compensation record

free company brief

This page is one director within Taysha Gene Therapies's record. The company brief lists every named executive and director, each linking to their own page.

Order TSHA

Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report